Aberrant Expression of CD56 in Patients With Hematologic Malignancies.
Aberrant Expression of CD56 in Patients With Hematologic Malignancies.
Recruiting · NCT04546945 · Registry updated 2026-03-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Aberrant Expression of CD56 in Patients With Hematologic Malignancies. | Hemic and Lymphatic Diseases, Neoplasms by Site, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm | Recruiting | Not stated | 2026-03-18 | NCT04546945 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Asmaa Hassan mohamed Abdel Mawjoud | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Assiut University | Asyut | Egypt | 48 |